Literature DB >> 11775462

Early detection of ovarian cancer: promise and reality.

Robert C Bast1, Nicole Urban, Viji Shridhar, David Smith, Zhen Zhang, Steven Skates, Karen Lu, Jinsong Liu, David Fishman, Gordon Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11775462     DOI： 10.1007/978-1-4757-3587-1_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  38 in total

1.  Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.

Authors:  Jun Pan; Hai-Quan Chen; Yi-Hua Sun; Jun-Hua Zhang; Xiao-Yang Luo
Journal:  Lung       Date:  2008-05-09       Impact factor: 2.584

Review 2.  The role of biomarkers in the management of epithelial ovarian cancer.

Authors:  Wei-Lei Yang; Zhen Lu; Robert C Bast
Journal:  Expert Rev Mol Diagn       Date:  2017-05-15       Impact factor: 5.225

Review 3.  Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.

Authors:  Robert C Bast
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

Review 4.  Proteomics in cancer screening and management in gynecologic cancer.

Authors:  Wei Hu; Weiguo Wu; Ryuji Kobayashi; John J Kavanagh
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 5.  Proteomic profiling in ovarian cancer.

Authors:  Geoffrey Kim; Lucas Minig; Elise C Kohn
Journal:  Int J Gynecol Cancer       Date:  2009-12       Impact factor: 3.437

6.  Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.

Authors:  Kristin Lm Boylan; John D Andersen; Lorraine B Anderson; LeeAnn Higgins; Amy Pn Skubitz
Journal:  Proteome Sci       Date:  2010-06-14       Impact factor: 2.480

7.  Ovarian cancer pathogenesis: a model in evolution.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  J Oncol       Date:  2009-09-06       Impact factor: 4.375

8.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.

Authors:  Melissa S DeRycke; John D Andersen; Katherine M Harrington; Stefan E Pambuccian; Steve E Kalloger; Kristin L M Boylan; Peter A Argenta; Amy P N Skubitz
Journal:  Am J Clin Pathol       Date:  2009-12       Impact factor: 2.493

10.  Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Authors:  Garnet L Anderson; Martin McIntosh; Lieling Wu; Matt Barnett; Gary Goodman; Jason D Thorpe; Lindsay Bergan; Mark D Thornquist; Nathalie Scholler; Nam Kim; Kathy O'Briant; Charles Drescher; Nicole Urban
Journal:  J Natl Cancer Inst       Date:  2009-12-30       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.